日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

GLUT1 expression, lymphocyte distribution and CD3(+) T-cell metabolic subsets as predictive markers of response to immunotherapy in advanced melanoma

GLUT1表达、淋巴细胞分布和CD3(+) T细胞代谢亚群作为晚期黑色素瘤免疫治疗反应的预测标志物

Paver, Elizabeth C; Gide, Tuba N; Yaseen, Zarwa; Cornejo-Paramo, Paola; Ferguson, Peter; Maher, Nigel G; Menzies, Alexander M; Carlino, Matteo S; da Silva, Ines Pires; Holst, Jeff; Long, Georgina V; Scolyer, Richard A; Wilmott, James S

Prospective tumour mutation burden and neoantigen profiling predicts immunotherapy response in metastatic melanoma

前瞻性肿瘤突变负荷和新抗原谱分析可预测转移性黑色素瘤的免疫治疗反应

Mao, Yizhe; Gide, Tuba N; Maher, Nigel G; Vignati, Danielle; Boutros, Andrea; Cornejo-Páramo, Paola; Potter, Alison J; Carlino, Matteo S; Paver, Elizabeth C; Burke, Hazel; Menzies, Alexander M; Lo, Serigne N; da Silva, Inês Pires; Scolyer, Richard A; Long, Georgina V; Vergara, Ismael A; Wilmott, James S

A randomised pilot trial of perioperative propranolol combined with celecoxib versus standard of care in stage III melanoma: The ProCel study protocol

围手术期普萘洛尔联合塞来昔布与标准治疗方案在 III 期黑色素瘤中的随机对照试验:ProCel 研究方案

Selvaraj, Katina J; Damian, Diona L; Lyons, J Guy; Wilmott, James S; Ferguson, Peter M; McGrady, Michele; Bartula, Iris; Lo, Serigne N; Scolyer, Richard A; Ferguson, Angela L; Saw, Robyn P M

Neoadjuvant triplet immune checkpoint blockade in newly diagnosed glioblastoma

新辅助三联免疫检查点阻断疗法治疗新诊断的胶质母细胞瘤

Georgina V Long ,Elena Shklovskaya ,Laveniya Satgunaseelan ,Yizhe Mao ,Inês Pires da Silva ,Kristen A Perry ,Russell J Diefenbach ,Tuba N Gide ,Brindha Shivalingam ,Michael E Buckland ,Maria Gonzalez ,Nicole Caixeiro ,Ismael A Vergara ,Xinyu Bai ,Robert V Rawson ,Edward Hsiao ,Umaimainthan Palendira ,Tri Giang Phan ,Alexander M Menzies ,Matteo S Carlino ,Camelia Quek ,Sean M Grimmond ,Joseph H A Vissers ,Dannel Yeo ,John E J Rasko ,Mustafa Khasraw ,Bart Neyns ,David A Reardon ,David M Ashley ,Helen Wheeler ,Michael Back ,Richard A Scolyer ,James Drummond ,James S Wilmott ,Helen Rizos

Tumor miRNA Signatures Associate with Outcomes of Patients with Stage II/III Melanoma

肿瘤 miRNA 特征与 II/III 期黑色素瘤患者的预后相关

Wiggins, Jennifer M; Zhang, Qiao; Zhang, Yian; Vand-Rajabpour, Fatemeh; Hanniford, Douglas; He, Linchen; Lu, Yuting; Kenney, Jessica M; Sadeghi, Keimya D; Argibay, Diana; Orlow, Irene; Busam, Klaus J; Lezcano, Cecilia; Lee, Tim K; Luo, Li; Gorlov, Ivan P; Amos, Christopher; Ernstoff, Marc S; Seshan, Venkatraman E; Cust, Anne E; Wilmott, James; Scolyer, Richard A; Mann, Graham J; Reiner, Allison; Kostrzewa, Caroline E; Nagore, Eduardo; Funchain, Pauline; Ko, Jennifer; Edmiston, Sharon N; Conway, Kathleen; Googe, Paul B; Ollila, David W; Lee, Jeffrey E; Rees, Judy R; Thompson, Cheryl L; Gerstenblith, Meg; Bosenberg, Marcus; Gould Rothberg, Bonnie E; Osman, Iman; Saenger, Yvonne; Reynolds, Adam Z; Boyce, Tawny; Holmen, Sheri; Yan, Shaofeng; Brunsgaard, Elise; Bogner, Paul; Kuan, Pei Fen; Thomas, Nancy E; Begg, Colin B; Shen, Ronglai; Berwick, Marianne; Shao, Yongzhao; Polsky, David; Hernando, Eva

Pathologist-Read vs AI-Driven Assessment of Tumor-Infiltrating Lymphocytes in Melanoma

病理学家解读与人工智能驱动的黑色素瘤肿瘤浸润淋巴细胞评估比较

Aung, Thazin N; Liu, Matthew; Su, David; Shafi, Saba; Boyaci, Ceren; Steen, Sanna; Tsiknakis, Nikolaos; Vidal, Joan Martinez; Maher, Nigel; Micevic, Goran; Tan, Samuel X; Vesely, Matthew D; Nourmohammadi, Saeed; Bai, Yalai; Djureinovic, Dijana; Wong, Pok Fai; Bates, Katherine; Chan, Nay N N; Gavirelatou, Niki; He, Mengni; Burela, Sneha; Barna, Robert; Bosic, Martina; Bräutigam, Konstantin; Illabochaca, Irineu; Chenhao, Zhou; Gama, Joao; Kreis, Bianca; Mohacsi, Reka; Pillar, Nir; Pinto, Joao; Poulios, Christos; Toli, Maria Angeliki; Tzoras, Evangelos; Bracero, Yadriel; Bosisio, Francesca; Cserni, Gábor; Dema, Alis; Fortarezza, Francesco; Gonzalez, Mercedes Solorzano; Gullo, Irene; Queipo Gutiérrez, Francisco Javier; Hacihasanoglu, Ezgi; Jovic, Viktor; Lazar, Bianca; Olinca, Maria; Neppl, Christina; Oliveira, Rui Caetano; Pezzuto, Federica; Gomes Pinto, Daniel; Plotar, Vanda; Pop, Ovidiu; Rau, Tilman; Skok, Kristijan; Sun, Wenwen; Serbes, Ezgi Dicle; Solass, Wiebke; Stanowska, Olga; Szasz, Marcell; Szymonski, Krzysztof; Thimm, Franziska; Vignati, Danielle; Vigdorovits, Alon; Prieto, Victor; Sinnberg, Tobias; Wilmott, James; Cowper, Shawn; Warrell, Jonathan; Saenger, Yvonne; Hartman, Johan; Plummer, Jasmine; Osman, Iman; Rimm, David L; Acs, Balazs

Do BRAF-targeted therapies have a role in the era of immunotherapy?

在免疫疗法时代,BRAF靶向疗法是否还有作用?

Braden, J; Conway, J W; Wilmott, J S; Scolyer, R A; Long, G V; da Silva, I P

Factors Associated With Implementation of Biomarker Testing and Strategies to Improve Its Clinical Uptake in Cancer Care: Systematic Review Using Theoretical Domains Framework

影响生物标志物检测实施及提高其在癌症治疗中临床应用率的策略:基于理论域框架的系统评价

Salam, Rehana A; Dunlop, Kate L A; Gide, Tuba N; Wilmott, James; Smith, Andrea; Cust, Anne E

Simulating the non-Hermitian dynamics of financial option pricing with quantum computers

利用量子计算机模拟金融期权定价的非厄米动力学

Kumar, Swagat; Wilmott, Colin Michael

Acceptability of self-completion versus face-to-face use of a vertebral fragility fracture clinical decision tool for use in older people with back pain in the UK

英国老年人背痛患者使用椎体脆性骨折临床决策工具时,自我填写与面对面使用方式的可接受性比较

Khalid, Tanzeela Y; Wilmott, Wendy; Shere, Clare; Peters, Tim J; Drew, Sarah; Paskins, Zoe; Clark, Emma M